On biomarkers and pathways in rectal cancer: What's the target?

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Rectal cancer treatment remains challenging, with high rates of recurrence and mortality.
• Metastatic rectal cancer is currently incurable, highlighting the need for novel therapeutic strategies.

Purpose of the Study:

• To review and assess recent validated biomarkers for rectal cancer.
• To identify potential therapeutic targets for improved rectal cancer management.
• To comment on recent advancements in colorectal cancer research.

Main Methods:

• Literature review of recent studies on rectal cancer biomarkers and targets.
• Analysis of validated biomarkers and emerging therapeutic targets.
• Critical commentary on a recent publication in Current Cancer Drug Targets.

Main Results:

• Several promising biomarkers and potential therapeutic targets have been identified in recent rectal cancer research.
• These advancements offer potential for improved early detection and personalized treatment strategies.
• The review synthesizes current knowledge and highlights areas for future investigation.

Conclusions:

• Continued research into novel biomarkers and therapeutic targets is crucial for improving rectal cancer patient outcomes.
• Targeted therapies hold promise for overcoming limitations of current treatment regimens.
• Further investigation is warranted to translate these findings into clinical practice.